First Trust NYSE Arca Biotechnology Index Fund Rating $163.92 +3.00 (+1.86%) As of 05/2/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy 2.67Holdings in FBT have an aggregate rating of Moderate Buy based on 530 analyst ratings issued in the past year covering 30 companies (100.0% of the portfolio).FBT Aggregate Price Target$163.92High Prediction$163.92Average Prediction$163.92Low Prediction$163.92Holdings in FBT have an aggregate price target of $163.92 and a range of $163.92 to $163.92 covering 30 companies (100.0% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 FBT Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.93%BNTXBioNTech$104.94+2.5%2.5975 of 5 stars2.89$143.44 36.7%18Upcoming EarningsPositive News3.80%SRPTSarepta Therapeutics$63.51+1.2%4.7232 of 5 stars2.83$157.95 148.7%23Upcoming EarningsPositive News3.72%RGENRepligen$141.51+3.1%4.6477 of 5 stars2.64$173.25 22.4%14Earnings ReportAnalyst UpgradeAnalyst RevisionNews CoverageGap Up3.66%NBIXNeurocrine Biosciences$109.68+2.9%4.8847 of 5 stars2.86$160.90 46.7%22Upcoming Earnings3.50%ONCBeigene$255.77+0.1%1.9905 of 5 stars3.00$318.88 24.7%6Analyst RevisionNews Coverage3.47%BMRNBioMarin Pharmaceutical$62.03-1.1%4.9303 of 5 stars2.70$92.95 49.9%23Analyst ForecastNews CoveragePositive NewsGap Up3.43%GMABGenmab A/S$21.48+2.6%4.4648 of 5 stars2.69$39.17 82.3%13Upcoming EarningsPositive News3.40%REGNRegeneron Pharmaceuticals$605.61+2.6%4.8427 of 5 stars2.88$892.60 47.4%26Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionHigh Trading Volume3.31%UTHRUnited Therapeutics$294.60+0.3%4.9879 of 5 stars2.67$392.00 33.1%12Earnings ReportAnalyst ForecastInsider TradePositive News3.31%EXELExelixis$39.60+1.8%4.0044 of 5 stars2.47$37.59 -5.1%19Short Interest ↑Analyst RevisionPositive News3.29%CORTCorcept Therapeutics$72.77+1.8%4.8157 of 5 stars3.00$143.25 96.9%5Upcoming EarningsShort Interest ↓News CoveragePositive News3.29%MRNAModerna$27.61+2.1%4.363 of 5 stars2.04$53.95 95.4%23Earnings ReportAnalyst ForecastNews CoverageGap Up3.29%WATWaters$351.16+2.7%4.0206 of 5 stars2.61$392.13 11.7%18Upcoming Earnings3.28%NTRANatera$156.66+3.5%2.9018 of 5 stars3.00$175.76 12.2%16Upcoming EarningsInsider TradePositive News3.26%INCYIncyte$62.53+0.8%4.7431 of 5 stars2.17$73.53 17.6%18Earnings ReportAnalyst ForecastAnalyst Revision3.26%ILMNIllumina$77.88+1.8%4.7181 of 5 stars2.48$137.55 76.6%21Upcoming EarningsAnalyst ForecastPositive News3.26%BIIBBiogen$123.53+2.2%4.7168 of 5 stars2.38$195.85 58.5%32Earnings ReportAnalyst ForecastNews Coverage3.25%ARGXargenx$649.67+1.5%2.5317 of 5 stars2.91$699.28 7.6%23Upcoming EarningsPositive NewsGap Up3.24%MTDMettler-Toledo International$1,103.95+4.5%3.7432 of 5 stars2.22$1,304.25 18.1%9Earnings ReportShort Interest ↑News CoveragePositive NewsHigh Trading Volume3.23%EXASExact Sciences$51.55+9.3%4.5218 of 5 stars2.95$70.90 37.5%22Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap UpHigh Trading Volume3.22%GILDGilead Sciences$103.68+0.4%4.7409 of 5 stars2.78$110.55 6.6%27Dividend Announcement3.22%KRYSKrystal Biotech$166.16+0.3%4.9139 of 5 stars3.00$222.71 34.0%8Upcoming EarningsAnalyst RevisionNews CoveragePositive News3.22%ALKSAlkermes$31.78+3.9%4.1859 of 5 stars2.67$38.33 20.6%12Earnings ReportAnalyst ForecastNews Coverage3.21%ALNYAlnylam Pharmaceuticals$259.39+1.7%4.2256 of 5 stars2.77$319.17 23.0%26Earnings ReportAnalyst DowngradeNews Coverage3.20%ACADACADIA Pharmaceuticals$14.91+2.3%4.2729 of 5 stars2.50$23.87 60.1%16Upcoming Earnings3.20%VRTXVertex Pharmaceuticals$501.15+0.5%3.9744 of 5 stars2.64$514.91 2.7%25Upcoming EarningsPositive News3.18%VCYTVeracyte$30.35+2.2%4.0058 of 5 stars2.70$42.60 40.4%10Upcoming EarningsShort Interest ↑Positive NewsHigh Trading Volume3.16%BRKRBruker$40.44+2.8%4.9851 of 5 stars2.55$65.00 60.7%11Upcoming EarningsShort Interest ↓Positive NewsHigh Trading Volume3.09%HALOHalozyme Therapeutics$61.19+1.9%4.0299 of 5 stars2.60$62.89 2.8%10Upcoming EarningsAnalyst Revision3.08%AMGNAmgen$281.22-0.9%4.0982 of 5 stars2.41$308.18 9.6%22Earnings ReportAnalyst ForecastPositive NewsGap Up This page (NYSEARCA:FBT) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredReal Americans Don’t Wait on Wall Street’s Next MoveWhat's happening in the markets right now should concern every freedom-loving American who's worked hard and s...Premier Gold Co | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology Index Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FBT Stock Free FBT Stock Alerts